Status:
UNKNOWN
Gluten for Autism Spectrum Disorders
Lead Sponsor:
Medical University of Warsaw
Collaborating Sponsors:
Nutricia Foundation
Conditions:
Autism Spectrum Disorders
Eligibility:
All Genders
3-6 years
Phase:
NA
Brief Summary
BACKGRUOUND: Autism spectrum disorder (ASD) is a common condition. The etiology of ASD remains unknown. Recent studies suggest a link between elimination diets and severity of autistic symptoms. The p...
Detailed Description
Autism Spectrum Disorder (ASD) is a neurodevelopmental lifelong disorder, significantly impairing the quality of life of patients and their families. The symptoms are thought to result from interactio...
Eligibility Criteria
Inclusion
- Children aged 3-5 and 11/12 years with a diagnosis of ASD
- GFD for at least 8 weeks prior to enrollment
- Minimal scores of 15 on SCQ
- Minimal scores 70 points on Leiter scale
- Consent of caregivers to participate in the study
Exclusion
- Gluten-mediated disease (celiac disease, wheat allergy)
- Lack of motivation / opportunity to follow a diet
- Malnutrition (defined according World Health Organization - WHO standards as weight for height \<-2 SDS - Standard Deviation Scores)
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT02280746
Start Date
September 1 2014
End Date
December 1 2015
Last Update
October 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Warsaw
Warsaw, Warsaw, Poland